Randomised clinical trial: the efficacy of treatment, guided by a shorter duration of response, using peginterferon alfa-2a plus ribavirin for hepatitis C virus other than genotypes 2 or 3.

Saved in:
Bibliographic Details
Title: Randomised clinical trial: the efficacy of treatment, guided by a shorter duration of response, using peginterferon alfa-2a plus ribavirin for hepatitis C virus other than genotypes 2 or 3.
Authors: Lee, S. S.1 (AUTHOR), Sherman, M.2 (AUTHOR), Ramji, A.3 (AUTHOR), Greenbloom, S.4 (AUTHOR), Elkashab, M.5 (AUTHOR), Pluta, H.6 (AUTHOR), Hilzenrat, N.7 (AUTHOR), Balshaw, R.8 (AUTHOR), Usaty, C.9 (AUTHOR), Myers, R. P.1 (AUTHOR)
Source: Alimentary Pharmacology & Therapeutics. Jan2012, Vol. 35 Issue 1, p37-47. 11p. 2 Diagrams, 3 Charts, 1 Graph.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:02692813
DOI:10.1111/j.1365-2036.2011.04911.x